Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare

Conditions:   Cutaneous Sarcoidosis;   Granuloma Annulare Intervention:   Drug: Tofacitinib 5 mg twice daily Sponsors:   Yale University;   Pfizer Recruiting

Source: ClinicalTrials.gov - April 10, 2019 Category: Research Source Type: clinical trials